 Adverse Reaction. An AE assessed as likely having a causal relationship with the intervention i.e., TheraGauzetobramycin. Specifically focusing on local-toxicity adverse reactions, we will evaluate for increasing redness, increasing pain or a new rash at the site of the packed wound. Increasing pain or redness could be due to progression of the infection cellulitisabscess or local toxicity or reaction to the tobramycin in the TheraGauzetobramycin packing. This will be assessed by an Investigator. Increasing purulent drainage or the identification of new areas of fluctuance requiring an additional incision and drainage procedure will be assessed as progression of the infection rather than evidence of local toxicity or reaction to the tobramycin. 